Quality of care in early detection and management of pre-eclampsia/eclampsia in health facilities in Afghanistan.
Afghanistan
Early Diagnosis
Eclampsia
/ diagnosis
Female
Health Facilities
/ standards
Humans
Magnesium Sulfate
/ therapeutic use
Pre-Eclampsia
/ diagnosis
Pregnancy
Prenatal Care
/ standards
Quality Assurance, Health Care
Quality of Health Care
/ statistics & numerical data
Tocolytic Agents
/ therapeutic use
Afghanistan
Pre-eclampsia
eclampsia
maternal health
quality of health care
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
18 Jan 2019
18 Jan 2019
Historique:
received:
27
07
2018
accepted:
11
12
2018
entrez:
20
1
2019
pubmed:
20
1
2019
medline:
9
5
2019
Statut:
epublish
Résumé
Afghanistan faces a high burden of maternal and neonatal morbidity and mortality. Hypertensive disorders of pregnancy, including pre-eclampsia and eclampsia (PE/E), are among the most common causes of maternal and neonatal complications. Hypertensive disorders of pregnancy can lead to fatal complications for both the mother and fetus. The 2016 Afghanistan National Maternal and Newborn Health Quality of Care Assessment assessed quality of early detection and management of PE/E in health facilities and skilled birth attendants' (SBAs) perceptions of their working environment. All accessible public health facilities with an average of at least five births per day (n = 77), a nationally representative sample of public health facilities with less than five births per day (n = 149), and 20 purposively selected private health facilities were assessed. Methods included a facility inventory and record review, interviews with SBAs, and direct clinical observation of antenatal care (ANC), intrapartum care and immediate postnatal care (PNC), as well as severe PE/E case management. Most facilities had supplies and medicines for early detection and management of PE/E. At public health facilities, 357 of 414 (86.2%) clients observed during ANC consultations had their blood pressure checked and 159 (38.4%) were asked if they had experienced symptoms of PE/E. Only 553 of 734 (72.6%) SBAs interviewed were able to correctly identify severe pre-eclampsia described in a case scenario. Of 29 PE/E cases observed, 17 women (59%) received the correct loading dose of magnesium sulfate (MgSO4) and 12 women (41%) received the correct maintenance dose of MgSO4. At private health facilities, 39 of 45 ANC clients had their blood pressure checked and 9 of 45 (20%) were asked about symptoms of PE/E. Fifty-four of 64(84.4%) SBAs in private facilities correctly identified severe pre-eclampsia described in a case scenario. Notable gaps in SBAs' knowledge and clinical practices in detection and management of PE/E in various health facilities increase the risk of maternal and perinatal mortality. Continuing education of health care providers and increased investment in focused quality improvement initiatives will be critical to improve the quality of health care services in Afghanistan.
Sections du résumé
BACKGROUND
BACKGROUND
Afghanistan faces a high burden of maternal and neonatal morbidity and mortality. Hypertensive disorders of pregnancy, including pre-eclampsia and eclampsia (PE/E), are among the most common causes of maternal and neonatal complications. Hypertensive disorders of pregnancy can lead to fatal complications for both the mother and fetus. The 2016 Afghanistan National Maternal and Newborn Health Quality of Care Assessment assessed quality of early detection and management of PE/E in health facilities and skilled birth attendants' (SBAs) perceptions of their working environment.
METHODS
METHODS
All accessible public health facilities with an average of at least five births per day (n = 77), a nationally representative sample of public health facilities with less than five births per day (n = 149), and 20 purposively selected private health facilities were assessed. Methods included a facility inventory and record review, interviews with SBAs, and direct clinical observation of antenatal care (ANC), intrapartum care and immediate postnatal care (PNC), as well as severe PE/E case management.
RESULTS
RESULTS
Most facilities had supplies and medicines for early detection and management of PE/E. At public health facilities, 357 of 414 (86.2%) clients observed during ANC consultations had their blood pressure checked and 159 (38.4%) were asked if they had experienced symptoms of PE/E. Only 553 of 734 (72.6%) SBAs interviewed were able to correctly identify severe pre-eclampsia described in a case scenario. Of 29 PE/E cases observed, 17 women (59%) received the correct loading dose of magnesium sulfate (MgSO4) and 12 women (41%) received the correct maintenance dose of MgSO4. At private health facilities, 39 of 45 ANC clients had their blood pressure checked and 9 of 45 (20%) were asked about symptoms of PE/E. Fifty-four of 64(84.4%) SBAs in private facilities correctly identified severe pre-eclampsia described in a case scenario.
CONCLUSION
CONCLUSIONS
Notable gaps in SBAs' knowledge and clinical practices in detection and management of PE/E in various health facilities increase the risk of maternal and perinatal mortality. Continuing education of health care providers and increased investment in focused quality improvement initiatives will be critical to improve the quality of health care services in Afghanistan.
Identifiants
pubmed: 30658606
doi: 10.1186/s12884-018-2143-0
pii: 10.1186/s12884-018-2143-0
pmc: PMC6339332
doi:
Substances chimiques
Tocolytic Agents
0
Magnesium Sulfate
7487-88-9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
36Subventions
Organisme : United States Agency for International Development
ID : HEMAYAT-Afghanistan
Références
Med J Aust. 2004 Mar 15;180(6 Suppl):S57-60
pubmed: 15012583
Int J Gynaecol Obstet. 2011 May;113(2):91-5
pubmed: 21349517
Int J Qual Health Care. 2013 Jul;25(3):270-6
pubmed: 23485422
PLoS One. 2013;8(3):e59158
pubmed: 23555626
Hum Resour Health. 2013 Oct 01;11:51
pubmed: 24083659
BMC Pregnancy Childbirth. 2013 Oct 12;13:186
pubmed: 24119329
Reprod Health. 2013;10 Suppl 1:S2
pubmed: 24625129
Lancet Glob Health. 2014 Jun;2(6):e323-33
pubmed: 25103301
Nagoya J Med Sci. 2015 Feb;77(1-2):103-11
pubmed: 25797975
Lancet. 2016 Mar 5;387(10022):999-1011
pubmed: 26342729
BMC Pregnancy Childbirth. 2015;15 Suppl 2:S2
pubmed: 26390886
Bull World Health Organ. 2015 Nov 1;93(11):759-67
pubmed: 26549903
Int J Gynaecol Obstet. 2016 Sep;134(3):233-6
pubmed: 27394067
Health Aff (Millwood). 2016 Sep 1;35(9):1716-24
pubmed: 27605655
Lancet. 2016 Oct 8;388(10053):1775-1812
pubmed: 27733286
Lancet Glob Health. 2017 May;5(5):e545-e555
pubmed: 28395847
Cochrane Database Syst Rev. 2017 Nov 17;11:CD011558
pubmed: 29148566
Global Health. 2017 Dec 06;13(1):88
pubmed: 29212509
BMC Pregnancy Childbirth. 2018 Mar 22;18(1):72
pubmed: 29566659
Lancet Glob Health. 2018 Nov;6(11):e1163-e1175
pubmed: 30309799